Physician profile
Ilan Cohen
NPI 1649374802
$5,445.12
in general payments reported to CMS, 2019-2025
16 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,250 · 2020: $119 · 2021: $337 · 2022: $76.41 · 2023: $210 · 2024: $1,101 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $3,117.78 | 2019 | |
| Alcon Vision LLC | $1,155.33 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $342.94 | 2022-2025 | Tecnis Iol, Tecnis Iol, Catalys System |
| New World Medical,INC. | $256.21 | 2020-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Amgen INC. | $137.00 | 2024 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.49 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $78.44 | 2022-2024 | Envista Mx60 Iol, Prolensa, Lotemax Sm |
| Sight Sciences, INC. | $66.34 | 2021-2025 | Omni Surgical System |
| Sun Pharmaceutical Industries INC. | $44.17 | 2019 | |
| Oyster Point Pharma, INC. | $35.11 | 2024 | Tyrvaya |
| Rayner Intraocular Lenses Limited | $31.03 | 2024 | Rayone Aspheric, Omidria, Rayone Emv |
| Allergan, INC. | $28.35 | 2021 | |
| Ocular Therapeutix, INC. | $21.87 | 2024 | Dextenza |
| Abbvie INC. | $16.83 | 2023 | Durysta |
| Novartis Pharmaceuticals Corporation | $13.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $13.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilan Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.